DEMO Pharmaceutical Industry S.A. today announced the pan-european registration of its Teicoplanin injection product (Talinac) is proceeding as planned.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.AcceptPrivacy policy